Orchestra BioMed is a biomedical innovation company focused on developing transformative therapeutic products for large unmet needs in procedure-based medicine.

Neovasc was a start-up medical device company targeting the cardiovascular marketplace that was acquired by Shockwave Medical.Led NASDAQ-listed company targeting the treatment of refractory angina and mitral valve disease. Drove strategy and execution, commercial operations, market access and reimbursement, business development, and capital investment and deploymentEXECUTIVE LEADERSHIP | GENERAL MANAGEMENT | CAPITAL RAISES | COMMERCIAL LEADERSHIP• Led successful exit by Shockwave Medical• Revitalized growth through cross-functional strategic reset of the company• Drive financing efforts to generate $100M+ in capital raises in four separate fundraising rounds• Led annual Operating Plan resulting in successive record quarterly and annual revenue growth• Achieved dedicated reimbursement in multiple geographies including U.S., Germany, France, and U.K.• Coordinated development of next generation transcatheter devices through pre-clinical efforts

VP Global Cardiovascular Therapies (St. Jude Medical) 2014 – 2017 VP Global Product Marketing 2013 - 2014VP Marketing - Cardiovascular Division 2012 – 2013Abbott is a global healthcare leader; 100,000 employees, $30B revenue Lead market development and share capture in global markets for innovative Cardiovascular and Neuromodulation devices. Drive strategy and tactical execution in the Americas, Europe, Asia, and emerging markets. Manage $3B in annual revenue.STRATEGY & EXECUTION | GENERAL MANAGEMENT | ACQUISITION INTEGRATION• Transformed Global Divisional Strategy for $3B Abbott Vascular Business Unit reinvigorating growth.• Led St. Jude Medical integration team to transform Abbott Vascular Business Unit. Merged sales and marketing teams and redesigned commercial model.• Directed global annual operating planning process.• Participated in global operating committee run by Divisional President to drive tactical execution. • Led four global cross-functional business leadership teams for vascular and structural heart businesses.• Spearheaded organization change management and cultural integration of the Vascular Division for $30B St. Jude Medical / Abbott merger.• Led $2.5B organizational integration of St. Jude Medical and Thoratec.GLOBAL MARKETING & COMMERCIALIZATION | PRODUCT INNOVATION• Directed global structural heart and vascular marketing teams, including strategy & execution.• Led upstream marketing efforts for 70+ product lines representing $10B across all St, Jude Medical business units: Cardiac Rhythm Management, Cardiovascular, Electrophysiology, and Neuromodulation. • Drove innovation, product development and commercialization efforts.• Coordinated with marketing teams to develop and launch innovative products.• Assumed U.S. Sales Leadership for 300+ commercial field team during integration of St. Jude into Abbott• Implemented Master Brand Strategy to transform and elevate corporate position to evolving customer base.

C.R. Bard (now part of Becton Dickson) is a global healthcare company focused on bringing innovation to healthcare providers.• Led development and execution of marketing strategy for the $600M+ peripheral vascular franchise.• Served as a member on the Executive Management Board.• Completed 12 new product launches generating total revenue in excess of $100M annually.• Drove LifeStent™ to market share leadership displacing Johnson & Johnson / Cordis.

Group Marketing Manager II 2006 - 2008Group Marketing Manager - Boston, MA 2004 - 2006 • Led $2B TAXUS Express® and TAXUS Liberte® brands across multiple marketing channels.• Developed Integrated Marketing Business Plan for the coronary stent franchise.• Drove global market share leadership in coronary drug-eluting stents.• Provided leadership and direction for $75M global Express® stent product family.• Coordinated and led U.S. launch of Express SD Biliary stent system.• Drove Express LD franchise to market leadership displacing Johnson & Johnson / Cordis.

• Led international peripheral vascular marketing teams that contributed $40M in annual revenue.• Developed and implemented Disease Solution marketing strategy across 12 global regions and 55 countries outside of the United States.• Co-managed 12 International Marketing Managers across global matrix structure.• Dramatically increased carotid therapy revenues through intense market development efforts.

Managed upstream and downstream marketing activities for urology balloon portfolio. Core Team Leader for percutaneous nephrolithotomy program. Developed pricing strategies to protect and grow key franchises.

Sales Awards: "Outstanding Sales Excellence Award" (National Award), "Territory Manager of the Year" (Rocky Mountain Region), "President's Club". Launched four new products in 22 territories. Achieved #1 ranking for new product sales five consecutive quarters

Consistently exceeded sales representative development and team financial goals